Clinical Trial Note A Comparison of Multimodality Treatment: Two and Four Courses of Neoadjuvant Chemotherapy Using S-1/CDDP or S-1/CDDP/ Docetaxel Followed by Surgery and S-1 Adjuvant Chemotherapy for Macroscopically Resectable Serosa-positive Gastric Cancer: A Randomized Phase II Trial (COMPASS-D Trial)

Department of Gastrointestinal Surgery, Kanagawa Cancer Center, Department of Biostatistics and Epidemiology, Yokohama City University Medical Center, Yokohama, Japan, Department of Surgery, Kitasato University, Sagamihara, Department of Surgery, Yokohama City University Medical Center, Yokohama, Department of Gastroenterological and General Surgery, Saint Marianna University, Kawasaki, Department of Gastroenterological Surgery, Aichi Cancer Center Hospital, Nagoya, Department of Gastrointestinal Surgery, Hiroshima University, Hiroshima, Department of Surgery, Osaka General Medical Center, Osaka and Department of Gastrointestinal Surgery, Aichi Cancer Center Aichi Hospital, Okazaki, Japan